Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €35.60 | €45.98 | 29.157% |
| Insmed Inc. | 15 | 1 | 3 | 1 | €24.40 | €42.72 | 75.064% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.44 | €50.33 | 24.463% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €10.70 | €21.00 | 96.295% |
| G1 Therapeutics | 15 | 1 | 2 | 0 | €4.29 | €10.56 | 146.245% |
| Esperion Therapeutis.Inc. | 14 | 0 | 2 | 0 | €2.06 | €8.39 | 306.702% |
| Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.35 | €184.76 | 22.075% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €23.57 | €60.55 | 156.911% |
| Geron Corp. | 12 | 0 | 2 | 0 | €3.46 | €4.63 | 33.616% |
| Corcept Therapeutics Inc. | 11 | 0 | 4 | 0 | €25.53 | €35.43 | 38.775% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €62.61 | €86.77 | 38.590% |
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.04 | €24.13 | 60.460% |
| Charles River Labs Intl | 10 | 0 | 1 | 0 | €212.20 | €248.57 | 17.139% |
| MacroGenics Inc. | 12 | 2 | 4 | 1 | €4.06 | €12.42 | 206.329% |
| Verastem Inc. | 10 | 0 | 1 | 0 | €11.10 | €24.63 | 121.935% |
| Rigel Pharmaceutical Inc. | 10 | 0 | 1 | 0 | €0.92 | €13.77 | 1403.603% |
| Celldex Therapeutics | 10 | 1 | 1 | 0 | €37.20 | €51.25 | 37.758% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Xencor Inc. | 10 | 1 | 2 | 0 | €22.60 | €32.58 | 44.154% |
| Chromadex Corp | 11 | 2 | 1 | 0 | €3.16 | €5.58 | 76.449% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €361.00 | €421.61 | 16.788% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.80 | €20.43 | 73.157% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €28.20 | €41.81 | 48.277% |